Tower Research Capital »

Polaryx Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Polaryx Therapeutics shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Polaryx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Polaryx Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Polaryx Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $14k 1.8k 7.56

More positions owned by Tower Research Capital

Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shares Etf Trust Daily Semiconduc (SOXL)
Apple (AAPL)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Alphabet Inc Cap Stk Cl A (GOOGL)
Ishares Tr Core Us Aggbd Et (AGG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)

View all positions for Tower Research Capital

Top funds holding Polaryx Therapeutics

Vanguard Capital Management
Geode Capital Management
Millennium Management
Vanguard Fiduciary Trust
State Street Corporation
BlackRock
Northern Trust
Bank of America Corporation
Goldman Sachs Group
UBS Group
Squarepoint Ops
Vanguard Global Advisers
Morgan Stanley
Tower Research Capital

View all funds holding Polaryx Therapeutics